% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@PHDTHESIS{Ernst:1032167,
author = {Ernst, Philipp},
title = {{E}xploring the process window for production of itaconic,
2 hydroxyparaconic, and itatartaric acid with engineered
{U}stilago strains},
volume = {293},
school = {Düsseldorf},
type = {Dissertation},
address = {Jülich},
publisher = {Forschungszentrum Jülich GmbH Zentralbibliothek, Verlag},
reportid = {FZJ-2024-06042},
isbn = {978-3-95806-825-4},
series = {Schriften des Forschungszentrums Jülich Reihe
Schlüsseltechnologien / Key Technologies},
pages = {x, 145},
year = {2025},
note = {Dissertation, Düsseldorf, 2024},
abstract = {To combat the current challenges of overpopulation, global
warming and the limited availability of fossil resources,
the linear petrochemical-based industry needs to be replaced
by a more sustainable bioeconomy. Therefore, economic
production of bio-based platform chemicals such as itaconic
acid is an emerging research topic. Itaconic acid is a
versatile monomer in the polymer industry and has also high
relevance in the medical and pharmaceutical sectors due to
its anti-microbial and anti-inflammatory properties. Up to
now, itaconic acid is commercially produced by the fungus
Aspergillus terreus, but its filamentous morphology poses
major limitations on bioprocess technology developments and
elevates production costs. Thus, current efforts are
focusing on the dimorphic basidiomycete Ustilago as an
alternative, natural itaconic acid producer, which offers
several advantages including a stable yeast-like morphology,
robustness and biosafety. In previous studies, Ustilago
maydis und Ustilago cynodontis have already been deeply
engineered to optimize itaconate production. In frame of
this thesis, established modifications from two different
itaconatehyperproducing U. maydis strains were consolidated
into one strain named U. maydis K14. This strain 1) features
stable yeast-like growth due to deletion of fuz7 involved in
filamentous development, 2) produces less byproducts due to
deletion of competing pathways (ΔMEL, ΔUA, Δdgat,
Δcyp3), and 3) circumvents enzymatic bottlenecks by
overproduction of the itaconate cluster regulator Ria1 and
the mitochondrial cis-aconitate transporter MttA from A.
terreus. A lower osmotolerance of U. maydis K14 as a side
effect of this engineering was counteracted by a continuous
glucose feeding strategy in high and low cell-density
fed-batch fermentations. With the latter strategy, high
product titers with the maximum theoretical
substrate-to-product yield of 0.72 ± 0.02 gITA gGLC-1
during the production phase were obtained, thereby mastering
one of the main challenges during fungal itaconate
production. However, improving economics is not just about
optimizing individual parameters such as yield, titer and
productivity, but also about minimizing main cost drivers
such as base and acid consumption during fermentation and
downstream processing, respectively. Using the previously
engineered and naturally acid-tolerant U. cynodontis ITA MAX
pH (Δfuz7 Δcyp3 PetefmttA Pria1ria1), the process window
of itaconate production with regard to pH was systematically
explored in continuous fed-batch fermentations aiming at a
rational analysis of operational costs. A subsequent
techno-economic analysis exposed that a production pH of 3.6
provided the best trade-off between yield, titer and
productivity on the one hand, and the use of base and acid
and associated salt waste production on the other hand.
While such process optimizations are usually carried out
using the conventional feedstock glucose, long-term
solutions for bio-based production processes envisage the
usage of unprocessed, low-cost feedstocks in order to
further reduce production costs and meet the circular
bioeconomy concept. In this context, this thesis revealed
the natural production of the amylolytic enzymes
glucoamylase and α-glucosidase by U. cynodontis ITA MAX pH,
enabling the utilization of starch as feedstock for
itaconate production. Production was optimized by
overexpression of an α-amylase gene otherwise not expressed
under the applied conditions. In addition to itaconate,
Ustilago species produce the two itaconate derivatives
2-hydroxyparaconate and itatartarate, which are potential
novel anti-microbial drug candidates. To restore
2-hydroxyparaconate and itatartarate production in U.
cynodontis ITA MAX pH, the itaconate-oxidizing P450
monooxygenase gene cyp3 was overexpressed under a
constitutive promotor, yielding a product mixture of
itaconate, 2-hydroxyparaconate and itatartarate. Derivatives
specificity was increased by using glycerol as alternative
carbon source, exchanging the native itaconate transporter
Itp1 with the one from A. terreus (MfsA), and low pH
conditions. In batch fermentations on glycerol, this strain
was able to produce 2-hydroxyparaconate and itatartarate
with 100 ± 0.0 $\%$ derivatives specificity, allowing
subsequent purification of both, not yet commercially
available products for structural and biochemical
characterization. In conclusion, this thesis demonstrates
that an integrated approach of strain and process
engineering can provide major advances for optimizing
economic feasibility of itaconate, 2-hydroxyparaconate and
itatartarate production with Ustilago species in a
biorefinery context, thereby enabling an expanded production
of bio-based building blocks of industrial and potentially
also pharmaceutical relevance.},
cin = {IBG-1},
cid = {I:(DE-Juel1)IBG-1-20101118},
pnm = {2171 - Biological and environmental resources for
sustainable use (POF4-217)},
pid = {G:(DE-HGF)POF4-2171},
typ = {PUB:(DE-HGF)3 / PUB:(DE-HGF)11},
urn = {urn:nbn:de:0001-2506171149098.453479022595},
doi = {10.34734/FZJ-2024-06042},
url = {https://juser.fz-juelich.de/record/1032167},
}